Intravenous pulsed steroids in rheumatoid arthritis: A comparative dose study

I. W. Iglehart, J. D. Sutton, J. C. Bender, R. A. Shaw, C. M. Ziminski, P. A. Holt, M. C. Hochberg, T. M. Zizic, E. W. Engle, M. B. Stevens

Research output: Contribution to journalArticlepeer-review

Abstract

This prospective, double blind study was undertaken to test the efficacy of intravenous 'minipulse' (100 mg) methylprednisolone (MP) therapy versus standard pulse (1000 mg) MP therapy in rheumatoid arthritis (RA). Thirty-six patients with RA synovitis flares were randomized to receive either 100 or 1000 mg MP IV QD x 3 doses. These 2 universally comparable groups exhibited no statistically significant differences in their striking prompt and sustained clinical improvement. These data suggest that minipulse MP is as efficacious as conventional pulse MP in the treatment of RA flares.

Original languageEnglish (US)
Pages (from-to)159-162
Number of pages4
JournalJournal of Rheumatology
Volume17
Issue number2
StatePublished - Jan 1 1990

Keywords

  • Methylprednisolone therapy
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Intravenous pulsed steroids in rheumatoid arthritis: A comparative dose study'. Together they form a unique fingerprint.

Cite this